LIAISON® SARS-CoV-2 Ag assay is a unique quantitative solution to detect suspected COVID-19 individuals, do contact tracing and rapidly implement isolation procedures for those patients who have been infected and might be able to spread SARS-CoV-2. LIAISON® SARS-CoV-2 Ag assay could help to keep the COVID-19 pandemic at bay, because specimens can be tested out rapidly in a great numbers.

  • Long TAT of molecular testing can preclude clinical utility of the test 
  • To offer a cost-effective solution alternative to RT-PCR 
  • Allow to process a high volume of samples and to improve traceability at time to result during outbreak 
  • To screen asymptomatic people and to identify the hidden sources of COVID-19 transmission

Liaison SARS-CoV-2 AG is manufactured in the United States by Diasorin Inc. and was approved by Health Canada on November 2, 2021.

Buy Liaison SARS-CoV-2 AG for Your WorkPlace

If your company or organization is interested in rapid testing solutions, contact us today for help procuring Liaison SARS-CoV-2 AG or other rapid tests approved by Health Canada. Our team at Rapid Test & Trace Canada can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.

Proudly trusted by hundreds of organizations across Canada

Stay up to date with Rapid Test & Trace Canada

Scroll to Top
Tweet
Share
Share
WhatsApp
Pin